Obserwuj
Piotr Kuna
Piotr Kuna
Professor of Medicine, Medical University of Lodz, Poland
Zweryfikowany adres z umed.lodz.pl
Tytuł
Cytowane przez
Cytowane przez
Rok
Allergic rhinitis and its impact on asthma (ARIA) 2008
J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias, ...
Allergy 63, 8-160, 2008
11696*2008
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision
JL Brożek, J Bousquet, CE Baena-Cagnani, S Bonini, GW Canonica, ...
Journal of Allergy and Clinical Immunology 126 (3), 466-476, 2010
4053*2010
Oral glucocorticoid–sparing effect of benralizumab in severe asthma
P Nair, S Wenzel, KF Rabe, A Bourdin, NL Lugogo, P Kuna, P Barker, ...
New England journal of medicine 376 (25), 2448-2458, 2017
9752017
International consensus on (ICON) pediatric asthma
NG Papadopoulos, H Arakawa, KH Carlsen, A Custovic, J Gern, ...
Allergy 67 (8), 976-997, 2012
8672012
Sub-Lingual Immunotherapy: World Allergy Organization Position Paper 2009
GW Canonica, J Bousquet, T Casale, RF Lockey, CE Baena-Cagnani, ...
World Allergy Organization Journal 2, 233-281, 2009
7172009
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
A Kaplan, D Ledford, M Ashby, J Canvin, JL Zazzali, E Conner, J Veith, ...
Journal of Allergy and Clinical Immunology 132 (1), 101-109, 2013
6392013
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
M Castro, SE Wenzel, ER Bleecker, E Pizzichini, P Kuna, WW Busse, ...
The Lancet Respiratory Medicine 2 (11), 879-890, 2014
5652014
GA (2) LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen)
J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias, ...
Allergy 63 (Suppl 86), 8-160, 2008
4902008
Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial
JC Virchow, V Backer, P Kuna, L Prieto, H Nolte, HH Villesen, C Ljørring, ...
Jama 315 (16), 1715-1725, 2016
4862016
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial
SE Dahlén, K Malmstrom, EWA Nizankowska, B Dahlén, P Kuna, ...
American journal of respiratory and critical care medicine 165 (1), 9-14, 2002
4522002
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation …
J Bousquet, HJ Schünemann, A Togias, C Bachert, M Erhola, PW Hellings, ...
Journal of Allergy and Clinical Immunology 145 (1), 70-80. e3, 2020
4282020
Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis
U Wahn, A Tabar, P Kuna, S Halken, A Montagut, O de Beaumont, ...
Journal of Allergy and Clinical Immunology 123 (1), 160-166. e3, 2009
4022009
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations
P Kuna, MJ Peters, AI Manjra, C Jorup, IP Naya, NE Martinez‐Jimenez, ...
International journal of clinical practice 61 (5), 725-736, 2007
3792007
MACVIA‐ARIA Sentinel NetworK for allergic rhinitis (MASK‐rhinitis): the new generation guideline implementation
J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, C Bachert, ...
Allergy 70 (11), 1372-1392, 2015
3072015
RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils.
P Kuna, SR Reddigari, TJ Schall, D Rucinski, MY Viksman, AP Kaplan
Journal of immunology (Baltimore, Md.: 1950) 149 (2), 636-642, 1992
2951992
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.
P Kuna, SR Reddigari, D Rucinski, JJ Oppenheim, AP Kaplan
The Journal of experimental medicine 175 (2), 489-493, 1992
2921992
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ...
The lancet respiratory medicine 7 (1), 46-59, 2019
2872019
ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
J Bousquet, PW Hellings, I Agache, A Bedbrook, C Bachert, ...
Clinical and translational allergy 6 (1), 47, 2016
2342016
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
J Bousquet, HJ Schünemann, PW Hellings, S Arnavielhe, C Bachert, ...
Journal of Allergy and Clinical Immunology 138 (2), 367-374. e2, 2016
2182016
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
J Bousquet, A Addis, I Adcock, I Agache, A Agusti, A Alonso, ...
European Respiratory Journal 44 (2), 304-323, 2014
2162014
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20